Sanofi Pasteur Launches 5-in-1 Vaccine in China

Pentaxim vaccine is the first acellular pertussis pentavalent vaccine in China against five deadly childhood diseases.

Sanofi Pasteur has launched Pentaxim, the first 5-in-1 combination vaccine in China, to immunise against diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b.

Pentaxim vaccine is the first acellular pertussis pentavalent vaccine in China against five deadly childhood diseases. It reduces the number of shots from twelve to four, and achieves the same level of protection as immunisation with single-antigen vaccines.

The launch of Pentaxim vaccine comes just 18 months after Sanofi Pasteur introduced the first and only Inactivated Poliomyelitis Vaccine (IPV) to China. It also adds to a long list of innovative vaccines that Sanofi Pasteur has brought to the country, including the first rabies vaccine, the first influenza vaccine and